HomeTagsParagonix Technologies

Paragonix Technologies

LUNGguard Donor Lung Preservation System: c Announces First-in-Man Use by Duke University Hospital

The LUNGguard System represents a radical advance from ice and off-the-shelf coolers that has been the standard-of-care for over 50 years of organ transplantation.

Expansion of Partnership Between Paragonix and the Lung Transplant Foundation To Accelerate Commercialization of Innovative Lung Preservation Technlogies

Paragonix is currently completing commercial development of the Paragonix SherpaLung™ Preservation System and expects the filing of FDA pre-market notification and European CE clearance by Q4 2019. The Paragonix SherpaLung™ Preservation System is designed to ensure optimal lung preservation during its journey from donor to recipient patient by incorporating medically proven and clinically validated preservation techniques combined with lung inflation pressure control, ensuring stable inflation pressure on the ground or during air transport.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version